APO Research
Talk to an analyst

APO RESEARCH · REPORT

Placental Exosomes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Placental Exosomes Market Outlook and Growth Opportunities 2026

24 December 2025200 pages

Choose your research edition.

Industry ResearchPlacental Exosomes Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Placental Exosomes Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Placental Exosomes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Placental Exosomes Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Placental Exosomes Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Placental Exosomes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Placental Exosomes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Placental Exosomes market include Shenzhen Shifangjie Technology Co., Ltd., Guidon Pharmaceutics, Enze Kangtai, Beike Biotechnology, ZenBio, RoosterBio, Paracrine Therapeutics, Kimera Labs and Japan Bio Products Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Placental Exosomes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Placental Exosomes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Placental Exosomes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Placental Exosomes market size, projected growth trends, production technologies, key applications, and end-use industries.

Placental Exosomes Segment by Company

Shenzhen Shifangjie Technology Co., Ltd.

Guidon Pharmaceutics

Enze Kangtai

Beike Biotechnology

ZenBio

RoosterBio

Paracrine Therapeutics

Kimera Labs

Japan Bio Products Co., Ltd.

ExoQure

EXO Biologics

Creative Biolabs

BioIVT

BioCat

Aegle Therapeutics

Advancexo

Placental Exosomes Segment by Type

Placental MSC-Exosomes

Endothelial-derived Exosomes

Trophoblast-derived Exosomes

Placental Exosomes Segment by Application

Disease Diagnosis

Disease Treatment

Others

Placental Exosomes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Placental Exosomes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Placental Exosomes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Placental Exosomes significant trends, drivers, influence factors in global and regions.

6. To analyze Placental Exosomes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placental Exosomes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Placental Exosomes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placental Exosomes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Placental Exosomes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Placental Exosomes industry.

Chapter 3: Detailed analysis of Placental Exosomes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Placental Exosomes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Placental Exosomes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Placental Exosomes Industry Trends Table 2. Placental Exosomes Industry Drivers Table 3. Placental Exosomes Industry Opportunities and Challenges Table 4. Placental Exosomes Industry Restraints Table 5. Global Placental Exosomes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Placental Exosomes Revenue Share by Company (2021-2026) Table 7. Global Placental Exosomes Sales Volume by Company (kg) & (2021-2026) Table 8. Global Placental Exosomes Sales Volume Share by Company (2021-2026) Table 9. Global Placental Exosomes Average Price (USD/g) of Company (2021-2026) Table 10. Global Placental Exosomes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Placental Exosomes Key Company Manufacturing Base & Headquarters Table 12. Global Placental Exosomes Company, Product Type & Application Table 13. Global Placental Exosomes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Placental Exosomes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Placental MSC-Exosomes Table 18. Significant Companies of Endothelial-derived Exosomes Table 19. Significant Companies of Trophoblast-derived Exosomes Table 20. Global Placental Exosomes Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Placental Exosomes Sales Volume by Type (2021-2026) & (kg) Table 22. Global Placental Exosomes Sales Volume by Type (2027-2032) & (kg) Table 23. Global Placental Exosomes Sales Volume Share by Type (2021-2026) Table 24. Global Placental Exosomes Sales Volume Share by Type (2027-2032) Table 25. Global Placental Exosomes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Placental Exosomes Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Placental Exosomes Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Placental Exosomes Sales Value Share by Type (2021-2026) Table 29. Global Placental Exosomes Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Disease Diagnosis Table 31. Significant Companies of Disease Treatment Table 32. Significant Companies of Others Table 33. Global Placental Exosomes Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Placental Exosomes Sales Volume by Application (2021-2026) & (kg) Table 35. Global Placental Exosomes Sales Volume by Application (2027-2032) & (kg) Table 36. Global Placental Exosomes Sales Volume Share by Application (2021-2026) Table 37. Global Placental Exosomes Sales Volume Share by Application (2027-2032) Table 38. Global Placental Exosomes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Placental Exosomes Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Placental Exosomes Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Placental Exosomes Sales Value Share by Application (2021-2026) Table 42. Global Placental Exosomes Sales Value Share by Application (2027-2032) Table 43. Global Placental Exosomes Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Placental Exosomes Sales by Region (2021-2026) & (kg) Table 45. Global Placental Exosomes Sales Market Share by Region (2021-2026) Table 46. Global Placental Exosomes Sales by Region (2027-2032) & (kg) Table 47. Global Placental Exosomes Sales Market Share by Region (2027-2032) Table 48. Global Placental Exosomes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Placental Exosomes Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Placental Exosomes Sales Value Share by Region (2021-2026) Table 51. Global Placental Exosomes Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Placental Exosomes Sales Value Share by Region (2027-2032) Table 53. Global Placental Exosomes Market Average Price (USD/g) by Region (2021-2026) Table 54. Global Placental Exosomes Market Average Price (USD/g) by Region (2027-2032) Table 55. Global Placental Exosomes Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Placental Exosomes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Placental Exosomes Sales by Country (2021-2026) & (kg) Table 58. Global Placental Exosomes Sales Market Share by Country (2021-2026) Table 59. Global Placental Exosomes Sales by Country (2027-2032) & (kg) Table 60. Global Placental Exosomes Sales Market Share by Country (2027-2032) Table 61. Global Placental Exosomes Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Placental Exosomes Sales Value Market Share by Country (2021-2026) Table 63. Global Placental Exosomes Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Placental Exosomes Sales Value Market Share by Country (2027-2032) Table 65. Shenzhen Shifangjie Technology Co., Ltd. Company Information Table 66. Shenzhen Shifangjie Technology Co., Ltd. Business Overview Table 67. Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 68. Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Product Portfolio Table 69. Shenzhen Shifangjie Technology Co., Ltd. Recent Development Table 70. Guidon Pharmaceutics Company Information Table 71. Guidon Pharmaceutics Business Overview Table 72. Guidon Pharmaceutics Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 73. Guidon Pharmaceutics Placental Exosomes Product Portfolio Table 74. Guidon Pharmaceutics Recent Development Table 75. Enze Kangtai Company Information Table 76. Enze Kangtai Business Overview Table 77. Enze Kangtai Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 78. Enze Kangtai Placental Exosomes Product Portfolio Table 79. Enze Kangtai Recent Development Table 80. Beike Biotechnology Company Information Table 81. Beike Biotechnology Business Overview Table 82. Beike Biotechnology Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 83. Beike Biotechnology Placental Exosomes Product Portfolio Table 84. Beike Biotechnology Recent Development Table 85. ZenBio Company Information Table 86. ZenBio Business Overview Table 87. ZenBio Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 88. ZenBio Placental Exosomes Product Portfolio Table 89. ZenBio Recent Development Table 90. RoosterBio Company Information Table 91. RoosterBio Business Overview Table 92. RoosterBio Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 93. RoosterBio Placental Exosomes Product Portfolio Table 94. RoosterBio Recent Development Table 95. Paracrine Therapeutics Company Information Table 96. Paracrine Therapeutics Business Overview Table 97. Paracrine Therapeutics Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 98. Paracrine Therapeutics Placental Exosomes Product Portfolio Table 99. Paracrine Therapeutics Recent Development Table 100. Kimera Labs Company Information Table 101. Kimera Labs Business Overview Table 102. Kimera Labs Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 103. Kimera Labs Placental Exosomes Product Portfolio Table 104. Kimera Labs Recent Development Table 105. Japan Bio Products Co., Ltd. Company Information Table 106. Japan Bio Products Co., Ltd. Business Overview Table 107. Japan Bio Products Co., Ltd. Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 108. Japan Bio Products Co., Ltd. Placental Exosomes Product Portfolio Table 109. Japan Bio Products Co., Ltd. Recent Development Table 110. ExoQure Company Information Table 111. ExoQure Business Overview Table 112. ExoQure Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 113. ExoQure Placental Exosomes Product Portfolio Table 114. ExoQure Recent Development Table 115. EXO Biologics Company Information Table 116. EXO Biologics Business Overview Table 117. EXO Biologics Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 118. EXO Biologics Placental Exosomes Product Portfolio Table 119. EXO Biologics Recent Development Table 120. Creative Biolabs Company Information Table 121. Creative Biolabs Business Overview Table 122. Creative Biolabs Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 123. Creative Biolabs Placental Exosomes Product Portfolio Table 124. Creative Biolabs Recent Development Table 125. BioIVT Company Information Table 126. BioIVT Business Overview Table 127. BioIVT Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 128. BioIVT Placental Exosomes Product Portfolio Table 129. BioIVT Recent Development Table 130. BioCat Company Information Table 131. BioCat Business Overview Table 132. BioCat Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 133. BioCat Placental Exosomes Product Portfolio Table 134. BioCat Recent Development Table 135. Aegle Therapeutics Company Information Table 136. Aegle Therapeutics Business Overview Table 137. Aegle Therapeutics Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 138. Aegle Therapeutics Placental Exosomes Product Portfolio Table 139. Aegle Therapeutics Recent Development Table 140. Advancexo Company Information Table 141. Advancexo Business Overview Table 142. Advancexo Placental Exosomes Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 143. Advancexo Placental Exosomes Product Portfolio Table 144. Advancexo Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Placental Exosomes Distributors List Table 148. Placental Exosomes Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Placental Exosomes Product Image Figure 2. Global Placental Exosomes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Placental Exosomes Sales (2021-2032) & (kg) Figure 5. Global Placental Exosomes Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Placental Exosomes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Placental MSC-Exosomes Image Figure 10. Endothelial-derived Exosomes Image Figure 11. Trophoblast-derived Exosomes Image Figure 12. Global Placental Exosomes Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Placental Exosomes Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Placental Exosomes Sales Volume Share by Type (2021-2032) Figure 15. Global Placental Exosomes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Placental Exosomes Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Placental Exosomes Sales Value Share by Type (2021-2032) Figure 18. Disease Diagnosis Image Figure 19. Disease Treatment Image Figure 20. Others Image Figure 21. Global Placental Exosomes Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Placental Exosomes Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Placental Exosomes Sales Volume Share by Application (2021-2032) Figure 24. Global Placental Exosomes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Placental Exosomes Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Placental Exosomes Sales Value Share by Application (2021-2032) Figure 27. Global Placental Exosomes Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Placental Exosomes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Placental Exosomes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Placental Exosomes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 32. North America Placental Exosomes Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Placental Exosomes Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Placental Exosomes Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 38. South America Placental Exosomes Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Placental Exosomes Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Placental Exosomes Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Placental Exosomes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Placental Exosomes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Placental Exosomes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Placental Exosomes Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Placental Exosomes Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Placental MSC-Exosomes
  • Endothelial-derived Exosomes
  • Trophoblast-derived Exosomes
Applications
  • Disease Diagnosis
  • Disease Treatment
  • Others
Companies covered
  • Shenzhen Shifangjie Technology Co., Ltd.
  • Guidon Pharmaceutics
  • Enze Kangtai
  • Beike Biotechnology
  • ZenBio
  • RoosterBio
  • Paracrine Therapeutics
  • Kimera Labs
  • Japan Bio Products Co., Ltd.
  • ExoQure
  • EXO Biologics
  • Creative Biolabs
  • BioIVT
  • BioCat
  • Aegle Therapeutics
  • Advancexo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Placental Exosomes Sales Value (2021-2032)
  4. 1.2.2 Global Placental Exosomes Sales Volume (2021-2032)
  5. 1.2.3 Global Placental Exosomes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Placental Exosomes Market Dynamics
  1. 2.1 Placental Exosomes Industry Trends
  2. 2.2 Placental Exosomes Industry Drivers
  3. 2.3 Placental Exosomes Industry Opportunities and Challenges
  4. 2.4 Placental Exosomes Industry Restraints
3 Placental Exosomes Market by Company
  1. 3.1 Global Placental Exosomes Company Revenue Ranking in 2025
  2. 3.2 Global Placental Exosomes Revenue by Company (2021-2026)
  3. 3.3 Global Placental Exosomes Sales Volume by Company (2021-2026)
  4. 3.4 Global Placental Exosomes Average Price by Company (2021-2026)
  5. 3.5 Global Placental Exosomes Company Ranking (2024-2026)
  6. 3.6 Global Placental Exosomes Company Manufacturing Base and Headquarters
  7. 3.7 Global Placental Exosomes Company Product Type and Application
  8. 3.8 Global Placental Exosomes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Placental Exosomes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Placental Exosomes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Placental Exosomes Market by Type
  1. 4.1 Placental Exosomes Type Introduction
  2. 4.1.1 Placental MSC-Exosomes
  3. 4.1.2 Endothelial-derived Exosomes
  4. 4.1.3 Trophoblast-derived Exosomes
  5. 4.2 Global Placental Exosomes Sales Volume by Type
  6. 4.2.1 Global Placental Exosomes Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Placental Exosomes Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Placental Exosomes Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Placental Exosomes Sales Value by Type
  10. 4.3.1 Global Placental Exosomes Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Placental Exosomes Sales Value by Type (2021-2032)
  12. 4.3.3 Global Placental Exosomes Sales Value Share by Type (2021-2032)
5 Placental Exosomes Market by Application
  1. 5.1 Placental Exosomes Application Introduction
  2. 5.1.1 Disease Diagnosis
  3. 5.1.2 Disease Treatment
  4. 5.1.3 Others
  5. 5.2 Global Placental Exosomes Sales Volume by Application
  6. 5.2.1 Global Placental Exosomes Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Placental Exosomes Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Placental Exosomes Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Placental Exosomes Sales Value by Application
  10. 5.3.1 Global Placental Exosomes Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Placental Exosomes Sales Value by Application (2021-2032)
  12. 5.3.3 Global Placental Exosomes Sales Value Share by Application (2021-2032)
6 Placental Exosomes Regional Sales and Value Analysis
  1. 6.1 Global Placental Exosomes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Placental Exosomes Sales by Region (2021-2032)
  3. 6.2.1 Global Placental Exosomes Sales by Region: 2021-2026
  4. 6.2.2 Global Placental Exosomes Sales by Region (2027-2032)
  5. 6.3 Global Placental Exosomes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Placental Exosomes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Placental Exosomes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Placental Exosomes Sales Value by Region (2027-2032)
  9. 6.5 Global Placental Exosomes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Placental Exosomes Sales Value (2021-2032)
  12. 6.6.2 North America Placental Exosomes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Placental Exosomes Sales Value (2021-2032)
  15. 6.7.2 Europe Placental Exosomes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Placental Exosomes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Placental Exosomes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Placental Exosomes Sales Value (2021-2032)
  21. 6.9.2 South America Placental Exosomes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Placental Exosomes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Placental Exosomes Sales Value Share by Country, 2025 VS 2032
7 Placental Exosomes Country-level Sales and Value Analysis
  1. 7.1 Global Placental Exosomes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Placental Exosomes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Placental Exosomes Sales by Country (2021-2032)
  4. 7.3.1 Global Placental Exosomes Sales by Country (2021-2026)
  5. 7.3.2 Global Placental Exosomes Sales by Country (2027-2032)
  6. 7.4 Global Placental Exosomes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Placental Exosomes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Placental Exosomes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Placental Exosomes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Placental Exosomes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Placental Exosomes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Placental Exosomes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Placental Exosomes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Placental Exosomes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Placental Exosomes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Placental Exosomes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Placental Exosomes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Placental Exosomes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Placental Exosomes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Placental Exosomes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Placental Exosomes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Placental Exosomes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Placental Exosomes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Placental Exosomes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Placental Exosomes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Placental Exosomes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Placental Exosomes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Placental Exosomes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Placental Exosomes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Placental Exosomes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Placental Exosomes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Placental Exosomes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Placental Exosomes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Placental Exosomes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Placental Exosomes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Placental Exosomes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Placental Exosomes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Placental Exosomes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Placental Exosomes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Shifangjie Technology Co., Ltd.
  2. 8.1.1 Shenzhen Shifangjie Technology Co., Ltd. Company Information
  3. 8.1.2 Shenzhen Shifangjie Technology Co., Ltd. Business Overview
  4. 8.1.3 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Product Portfolio
  6. 8.1.5 Shenzhen Shifangjie Technology Co., Ltd. Recent Developments
  7. 8.2 Guidon Pharmaceutics
  8. 8.2.1 Guidon Pharmaceutics Company Information
  9. 8.2.2 Guidon Pharmaceutics Business Overview
  10. 8.2.3 Guidon Pharmaceutics Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guidon Pharmaceutics Placental Exosomes Product Portfolio
  12. 8.2.5 Guidon Pharmaceutics Recent Developments
  13. 8.3 Enze Kangtai
  14. 8.3.1 Enze Kangtai Company Information
  15. 8.3.2 Enze Kangtai Business Overview
  16. 8.3.3 Enze Kangtai Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Enze Kangtai Placental Exosomes Product Portfolio
  18. 8.3.5 Enze Kangtai Recent Developments
  19. 8.4 Beike Biotechnology
  20. 8.4.1 Beike Biotechnology Company Information
  21. 8.4.2 Beike Biotechnology Business Overview
  22. 8.4.3 Beike Biotechnology Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beike Biotechnology Placental Exosomes Product Portfolio
  24. 8.4.5 Beike Biotechnology Recent Developments
  25. 8.5 ZenBio
  26. 8.5.1 ZenBio Company Information
  27. 8.5.2 ZenBio Business Overview
  28. 8.5.3 ZenBio Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ZenBio Placental Exosomes Product Portfolio
  30. 8.5.5 ZenBio Recent Developments
  31. 8.6 RoosterBio
  32. 8.6.1 RoosterBio Company Information
  33. 8.6.2 RoosterBio Business Overview
  34. 8.6.3 RoosterBio Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 RoosterBio Placental Exosomes Product Portfolio
  36. 8.6.5 RoosterBio Recent Developments
  37. 8.7 Paracrine Therapeutics
  38. 8.7.1 Paracrine Therapeutics Company Information
  39. 8.7.2 Paracrine Therapeutics Business Overview
  40. 8.7.3 Paracrine Therapeutics Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Paracrine Therapeutics Placental Exosomes Product Portfolio
  42. 8.7.5 Paracrine Therapeutics Recent Developments
  43. 8.8 Kimera Labs
  44. 8.8.1 Kimera Labs Company Information
  45. 8.8.2 Kimera Labs Business Overview
  46. 8.8.3 Kimera Labs Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kimera Labs Placental Exosomes Product Portfolio
  48. 8.8.5 Kimera Labs Recent Developments
  49. 8.9 Japan Bio Products Co., Ltd.
  50. 8.9.1 Japan Bio Products Co., Ltd. Company Information
  51. 8.9.2 Japan Bio Products Co., Ltd. Business Overview
  52. 8.9.3 Japan Bio Products Co., Ltd. Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Japan Bio Products Co., Ltd. Placental Exosomes Product Portfolio
  54. 8.9.5 Japan Bio Products Co., Ltd. Recent Developments
  55. 8.10 ExoQure
  56. 8.10.1 ExoQure Company Information
  57. 8.10.2 ExoQure Business Overview
  58. 8.10.3 ExoQure Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ExoQure Placental Exosomes Product Portfolio
  60. 8.10.5 ExoQure Recent Developments
  61. 8.11 EXO Biologics
  62. 8.11.1 EXO Biologics Company Information
  63. 8.11.2 EXO Biologics Business Overview
  64. 8.11.3 EXO Biologics Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 EXO Biologics Placental Exosomes Product Portfolio
  66. 8.11.5 EXO Biologics Recent Developments
  67. 8.12 Creative Biolabs
  68. 8.12.1 Creative Biolabs Company Information
  69. 8.12.2 Creative Biolabs Business Overview
  70. 8.12.3 Creative Biolabs Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Creative Biolabs Placental Exosomes Product Portfolio
  72. 8.12.5 Creative Biolabs Recent Developments
  73. 8.13 BioIVT
  74. 8.13.1 BioIVT Company Information
  75. 8.13.2 BioIVT Business Overview
  76. 8.13.3 BioIVT Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BioIVT Placental Exosomes Product Portfolio
  78. 8.13.5 BioIVT Recent Developments
  79. 8.14 BioCat
  80. 8.14.1 BioCat Company Information
  81. 8.14.2 BioCat Business Overview
  82. 8.14.3 BioCat Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BioCat Placental Exosomes Product Portfolio
  84. 8.14.5 BioCat Recent Developments
  85. 8.15 Aegle Therapeutics
  86. 8.15.1 Aegle Therapeutics Company Information
  87. 8.15.2 Aegle Therapeutics Business Overview
  88. 8.15.3 Aegle Therapeutics Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Aegle Therapeutics Placental Exosomes Product Portfolio
  90. 8.15.5 Aegle Therapeutics Recent Developments
  91. 8.16 Advancexo
  92. 8.16.1 Advancexo Company Information
  93. 8.16.2 Advancexo Business Overview
  94. 8.16.3 Advancexo Placental Exosomes Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Advancexo Placental Exosomes Product Portfolio
  96. 8.16.5 Advancexo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Placental Exosomes Value Chain Analysis
  2. 9.1.1 Placental Exosomes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Placental Exosomes Sales Mode & Process
  6. 9.2 Placental Exosomes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Placental Exosomes Distributors
  9. 9.2.3 Placental Exosomes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst